4
Changes in Ownership
Coherus Oncology, Inc. Filed Acc 0001209191-14-067906
Director acquired 26,505 shares (option exercise)
- Director acquired 55,287 shares (conversion)
- Director disposed of 2,956 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Richards Christos · Director
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2014-11-12 | Option exercise : show line 1 in the form | +26,505 | $1.67 | $44,184 | 26,505 | D |
| 2014-11-12 | Other disposition : show line 2 in the form | −2,956 | 23,549 | D | ||
| 2014-11-12 | Conversion : show line 3 in the form | +39,991 | 63,540 | D | ||
| 2014-11-12 | Conversion : show line 4 in the form | +12,672 | 76,212 | D | ||
| 2014-11-12 | Conversion : show line 5 in the form | +2,624 | 78,836 | D |
Table II: Derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2014-11-12 | Option exercise : show line 6 in the form Warrant to Purchase Common Stock | −26,505 | 0 | D | ||
| 2014-11-12 | Option exercise : show line 7 in the form Warrant to Purchase Series B Preferred Stock | −429 | 0 | D | ||
| 2014-11-12 | Option exercise : show line 8 in the form Series B Preferred Stock | +429 | $0.02 | $7 | 12,673 | D |
| 2014-11-12 | Other disposition : show line 9 in the form Series B Preferred Stock | −1 | 12,672 | D | ||
| 2014-11-12 | Conversion : show line 10 in the form Series A Preferred Stock | −39,991 | 0 | D | ||
| 2014-11-12 | Conversion : show line 11 in the form Series B Preferred Stock | −12,672 | 0 | D | ||
| 2014-11-12 | Conversion : show line 12 in the form Series C Preferred Stock | −2,624 | 0 | D |
Loading xslF345X03/doc4.xml…